Literature DB >> 15292008

Hyperhomocysteinemia, pregnancy complications, and the timing of investigation.

Régine P Steegers-Theunissen1, Carola A Van Iersel, Petronella G Peer, Willianne L Nelen, Eric A Steegers.   

Abstract

OBJECTIVE: To assess associations between vitamin-dependent homocysteine metabolism and vascular-related pregnancy complications by considering interval between delivery and postpartum investigation and maternal age.
METHODS: Case-control study performed at the University Medical Center Nijmegen in the Netherlands. Patients had experienced pregnancy-induced hypertension (n = 37), preeclampsia (n = 144), hemolysis, elevated liver enzymes, low platelets (HELLP) syndrome (n = 104), recurrent early pregnancy loss (n = 544), abruptio placentae (n = 135), intrauterine growth restriction (n = 144), or intrauterine fetal death (n = 104). Controls comprised 176 women with uncomplicated obstetric histories. Oral methionine loading tests and fasting vitamin profiles were performed more than 6 weeks after delivery. Odds ratios and 95% confidence intervals were calculated after logistic regression analysis.
RESULTS: Hyperhomocysteinemia was associated with an approximately 2-fold to 3-fold increased risk for pregnancy-induced hypertension, abruptio placentae, and intrauterine growth restriction. Cobalamin deficiency was associated with HELLP syndrome, abruptio placentae, intrauterine growth restriction, and intrauterine fetal death. Pyridoxal 5-phosphate deficiency increased the risk for pregnancy-induced hypertension 4-fold. These associations lost their significance after adjustment for time interval and maternal age. High red cell folate was associated with a decreased risk for abruptio placentae and intrauterine growth restriction. An increased creatinine concentration was associated with pregnancy-induced hypertension, preeclampsia, HELLP syndrome, and abruptio placentae.
CONCLUSION: Hyperhomocysteinemia and vitamin deficiencies are largely determined by the interval between delivery and postpartum investigation and by maternal age. Time interval and maternal age should be considered in the risk estimation for vascular-related pregnancy complications.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15292008     DOI: 10.1097/01.AOG.0000129955.47943.2a

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  17 in total

1.  Complete deficiency of methylenetetrahydrofolate reductase in mice is associated with impaired retinal function and variable mortality, hematological profiles, and reproductive outcomes.

Authors:  Andrea K Lawrance; Julie Racine; Liyuan Deng; Xiaoling Wang; Pierre Lachapelle; Rima Rozen
Journal:  J Inherit Metab Dis       Date:  2010-06-08       Impact factor: 4.982

Review 2.  Periconceptional folic acid fortification for the risk of gestational hypertension and pre-eclampsia: a meta-analysis of prospective studies.

Authors:  Xiaorong Yang; Hui Chen; Yihui Du; Shuting Wang; Zhiping Wang
Journal:  Matern Child Nutr       Date:  2015-08-11       Impact factor: 3.092

3.  Maternal Mthfd1 disruption impairs fetal growth but does not cause neural tube defects in mice.

Authors:  Anna E Beaudin; Cheryll A Perry; Sally P Stabler; Robert H Allen; Patrick J Stover
Journal:  Am J Clin Nutr       Date:  2012-02-29       Impact factor: 7.045

4.  Genetic evaluation and counseling of couples with recurrent miscarriage: recommendations of the National Society of Genetic Counselors.

Authors:  Mercy Y Laurino; Robin L Bennett; Devki S Saraiya; Lisa Baumeister; Debra Lochner Doyle; Kathleen Leppig; Barbara Pettersen; Robert Resta; Larry Shields; Stefanie Uhrich; Elizabeth A Varga; Wendy H Raskind
Journal:  J Genet Couns       Date:  2005-06       Impact factor: 2.537

Review 5.  Perinatal folate supply: relevance in health outcome parameters.

Authors:  Katalin Fekete; Cristiana Berti; Irene Cetin; Maria Hermoso; Berthold V Koletzko; Tamás Decsi
Journal:  Matern Child Nutr       Date:  2010-10       Impact factor: 3.092

6.  Hyperhomocysteinemia as a Risk Factor for IUGR.

Authors:  Kiran Pandey; Preeti Dubay; Ajay Bhagoliwal; Neena Gupta; Geetika Tyagi
Journal:  J Obstet Gynaecol India       Date:  2012-10-16

7.  Thrombus obstructing the right ventricle outflow tract in a neonate with methylenetetrahydrofolate reductase 677TT genotype.

Authors:  Lubica Kovacikova; Peter Skrak; Martin Zahorec
Journal:  Eur J Pediatr       Date:  2011-03-08       Impact factor: 3.183

8.  Oxidative stress elevated DNA damage and homocysteine level in normal pregnant women in a segment of Pakistani population.

Authors:  Shazia A Bukhari; Muhammad Ibrahim Rajoka; Z Ibrahim; Fatima Jalal; Shahid Mahboob Rana; Saeed A Nagra
Journal:  Mol Biol Rep       Date:  2010-11-24       Impact factor: 2.316

9.  A comparative study of folate and vitamin B12 serum levels in preeclamptic versus normotensive pregnant women in correlation with uterine and umbilical artery Doppler findings and pregnancy outcome.

Authors:  Ahmed Mahmoud; Eman A Elkattan; Ashraf A Eldaly; Eman F Omran; Iman Mandour
Journal:  J Turk Ger Gynecol Assoc       Date:  2009-09-01

10.  Relationship between dietary folate intakes, maternal plasma total homocysteine and B-vitamins during pregnancy and fetal growth in Japan.

Authors:  Hidemi Takimoto; Natsuko Mito; Keizo Umegaki; Asako Ishiwaki; Kaoru Kusama; Shiro Abe; Machi Yamawaki; Hideoki Fukuoka; Chitaru Ohta; Nobuo Yoshiike
Journal:  Eur J Nutr       Date:  2007-07-11       Impact factor: 5.614

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.